xPedite: A Study to Expedite DIPG and DMG Research
NCT06140719 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2024-04-30
Summary
This study will gather data from new and existing patients with patient medical records, and patient/family/caregiver reported information to establish a clear natural history of disease suitable to serve as an external, contemporary or historical control arm for future therapeutic development programs of drugs, devices, or biologic interventions in DMG or DIPG.
Conditions
- Oncology
- DIPG
- DMG
Sponsors & Collaborators
-
xCures
lead INDUSTRY
Principal Investigators
-
Mark Shapiro, PhD · xCures
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2026-09-30
- Completion
- 2027-01-31
Countries
- United States
Study Locations
More Related Trials
-
Study of Capecitabine to Treat Recurrent High Grade Gliomas
NCT00717197 ·Status: COMPLETED ·Phase: PHASE2
-
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
NCT00226668 ·Status: WITHDRAWN ·Phase: PHASE3
-
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
NCT00126412 ·Status: COMPLETED ·Phase: PHASE3
-
A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects
NCT03028246 ·Status: RECRUITING ·Phase: NA
-
MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma
NCT03566199 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL
NCT00734773 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
NCT02101905 ·Status: COMPLETED ·Phase: PHASE1
-
Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
NCT04417088 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
NCT03422094 ·Status: TERMINATED ·Phase: PHASE1
-
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
NCT03465618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
NCT00704288 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)
NCT06463184 ·Status: WITHDRAWN ·Phase: PHASE1
-
Phase I Study of APX005M in Pediatric Central Nervous System Tumors
NCT03389802 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
NCT07206849 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents
NCT01517776 ·Status: TERMINATED ·Phase: PHASE2
-
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
NCT05717153 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors
NCT01473485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses
NCT03620032 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
NCT04015700 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
NCT05267106 ·Status: TERMINATED ·Phase: PHASE2
-
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
NCT04943848 ·Status: RECRUITING ·Phase: PHASE1
-
Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
NCT05879120 ·Status: WITHDRAWN ·Phase: PHASE2
-
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
NCT00548938 ·Status: TERMINATED ·Phase: PHASE2
-
CD147-CART Cells in Patients With Recurrent Malignant Glioma.
NCT04045847 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse
NCT03779230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2